Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The protein corona hampers the transcytosis of transferrin-modified nanoparticles through blood–brain barrier and attenuates their targeting ability to brain tumor
Wei Xiao, Yazhen Wang, Huilin Zhang, et al.
Biomaterials (2021) Vol. 274, pp. 120888-120888
Closed Access | Times Cited: 129

Showing 1-25 of 129 citing articles:

Chemical and Biophysical Signatures of the Protein Corona in Nanomedicine
Jiayu Ren, Nikolaos K. Andrikopoulos, Kelly Velonia, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 21, pp. 9184-9205
Closed Access | Times Cited: 187
The effects of protein corona on in vivo fate of nanocarriers
Qingqing Xiao, Makhloufi Zoulikha, Min Qiu, et al.
Advanced Drug Delivery Reviews (2022) Vol. 186, pp. 114356-114356
Closed Access | Times Cited: 137
A Historical Review of Brain Drug Delivery
William M. Pardridge
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1283-1283
Open Access | Times Cited: 132
Current research trends of nanomedicines
Qiuyue Liu, Jiahui Zou, Zhongjian Chen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4391-4416
Open Access | Times Cited: 82
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
Shuai Zha, Haitao Liu, Hengde Li, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1820-1845
Open Access | Times Cited: 80
The impact of protein corona on the biological behavior of targeting nanomedicines
Masoud Farshbaf, Hadi Valizadeh, Yunes Panahi, et al.
International Journal of Pharmaceutics (2022) Vol. 614, pp. 121458-121458
Closed Access | Times Cited: 72
An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor
Annu, Ali Sartaj, Zufika Qamar, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 70
A detailed insight of the tumor targeting using nanocarrier drug delivery system
Sibgha Batool, Saba Sohail, Fakhar ud Din, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 59
Mannose-Integrated Nanoparticle Hitchhike Glucose Transporter 1 Recycling to Overcome Various Barriers of Oral Delivery for Alzheimer’s Disease Therapy
Ting Lei, Zixiao Yang, Chaoqing Jiang, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3234-3250
Closed Access | Times Cited: 25
Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood–Brain Barrier
Zih-An Chen, C.‐H. Wu, Si‐Han Wu, et al.
ACS Nano (2024) Vol. 18, Iss. 20, pp. 12716-12736
Open Access | Times Cited: 22
Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulation
Yaxian Zheng, Shiqin Luo, Min Xu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3876-3900
Open Access | Times Cited: 20
Protein Coronas Derived from Mucus Act as Both Spear and Shield to Regulate Transferrin Functionalized Nanoparticle Transcellular Transport in Enterocytes
Dan Yang, Yu‐Qi Feng, Ying Yuan, et al.
ACS Nano (2024) Vol. 18, Iss. 10, pp. 7455-7472
Closed Access | Times Cited: 18
Control of biomedical nanoparticle distribution and drug release in vivo by complex particle design strategies
Melanie Bresinskya, Achim Goepfericha
European Journal of Pharmaceutics and Biopharmaceutics (2025), pp. 114634-114634
Open Access | Times Cited: 2
Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery
Woojun Kim, Nhu Ky Ly, Yanying He, et al.
Advanced Drug Delivery Reviews (2022) Vol. 192, pp. 114635-114635
Open Access | Times Cited: 69
Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma
Maria João Ramalho, Joana A. Loureiro, Manuel A. N. Coelho, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 279-279
Open Access | Times Cited: 62
The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System
Tianwei Li, Xiaoqing Li, Guiping Han, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 21-21
Open Access | Times Cited: 58
Salmonella-mediated blood‒brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy
Ze Mi, Qing Yao, Yan Qi, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 819-833
Open Access | Times Cited: 51
Intelligent lesion blood–brain barrier targeting nano-missiles for Alzheimer's disease treatment by anti-neuroinflammation and neuroprotection
Xueqin He, Xiaorong Wang, Lianyi Yang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 4, pp. 1987-1999
Open Access | Times Cited: 50
How Nanoparticles Open the Paracellular Route of Biological Barriers: Mechanisms, Applications, and Prospects
Junrong Wu, Zhenjun Zhu, Wenjing Liu, et al.
ACS Nano (2022) Vol. 16, Iss. 10, pp. 15627-15652
Closed Access | Times Cited: 49
Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy
Suliman Khan, Majid Sharifi, Jason P. Gleghorn, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 127-147
Open Access | Times Cited: 47
Overcoming the Blood–Brain Barrier for Gene Therapy via Systemic Administration of GSH‐Responsive Silica Nanocapsules
Yuyuan Wang, Xiuxiu Wang, Ruosen Xie, et al.
Advanced Materials (2022) Vol. 35, Iss. 6
Open Access | Times Cited: 45
Nanomedicine for Diagnosis and Treatment of Atherosclerosis
Jingyun Cheng, Hui Huang, Yu Chen, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 39
The role of protein corona on nanodrugs for organ-targeting and its prospects of application
Sijie Wang, Junlei Zhang, Huan‐Li Zhou, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 15-43
Closed Access | Times Cited: 35
Nanoparticles for Drug and Gene Delivery in Pediatric Brain Tumors’ Cancer Stem Cells: Current Knowledge and Future Perspectives
Luana Abballe, Zaira Spinello, Celeste Antonacci, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 505-505
Open Access | Times Cited: 30
Transferrin receptor 1 targeted nanomedicine for brain tumor therapy
Jianru Li, Zixia Zhang, Baoli Zhang, et al.
Biomaterials Science (2023) Vol. 11, Iss. 10, pp. 3394-3413
Closed Access | Times Cited: 28
Page 1 - Next Page

Scroll to top